midi tirzepatide How Much Weight Comes Back After You Stop Using a Weight-Loss Drug? the dual Weight Loss Medication | Medicine

After 36 weeks, the placebo group had lost an average of 2.3%, or 5.3 pounds, compared to 9.4% to 14.7%, or 21.6 to 34 pounds, in the orforglipron groups

Each schedule splits the total weekly amount differently

Clinical trials have demonstrated that it significantly lowers HbA1c levels and promotes substantial weight loss in individuals with type 2 diabetes and obesity

Other medical conditions and medications : Wegovy may not be suitable if you have certain other conditions, such as severe gastrointestinal disease, a history of pancreatitis, diabetic retinopathy (if you have type 2 diabetes), or kidney impairment